Sensus Healthcare (SRTS) Cash & Equivalents Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Sensus Healthcare | 47.41 Mn | 29.09 Mn | - | -3.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.91% |
| Dec 31, 2025 | 0.12% |
| Sep 30, 2025 | 8.40% |
| Jun 30, 2025 | 16.81% |
| Mar 31, 2025 | 29.49% |
| Dec 31, 2024 | -4.72% |
| Sep 30, 2024 | 10.11% |
| Jun 30, 2024 | -5.39% |
| Mar 31, 2024 | -23.85% |
| Dec 31, 2023 | -9.29% |
| Sep 30, 2023 | -45.48% |
| Jun 30, 2023 | -40.50% |
| Mar 31, 2023 | -41.09% |
| Dec 31, 2022 | 75.77% |
| Sep 30, 2022 | 129.25% |
| Jun 30, 2022 | 121.67% |
| Mar 31, 2022 | 140.48% |
| Dec 31, 2021 | -2.60% |
| Sep 30, 2021 | 1.64% |
| Jun 30, 2021 | -17.44% |
| Mar 31, 2021 | 12.85% |
| Dec 31, 2020 | 84.04% |
| Sep 30, 2020 | 133.54% |
| Jun 30, 2020 | 61.05% |
| Mar 31, 2020 | 93.51% |
| Dec 31, 2019 | -35.12% |
| Sep 30, 2019 | -59.67% |
| Jun 30, 2019 | 42.70% |
| Mar 31, 2019 | -34.30% |
| Dec 31, 2018 | 23.78% |
| Sep 30, 2018 | 150.37% |
| Jun 30, 2018 | 89.66% |
| Mar 31, 2018 | 202.95% |
| Dec 31, 2017 | 100.01% |
| Jun 30, 2017 | -73.19% |
| Dec 31, 2016 | -0.45% |